BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7522476)

  • 1. Epithelial antigens in carcinomas of the ovaries. Relation to histological classification.
    Jørgensen A; Nielsen K
    APMIS; 1994 Jul; 102(7):533-7. PubMed ID: 7522476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An immunohistochemical study of intestinal mucinous antigens and CEA in ovarian epithelial tumors].
    Liu A; Wang M; Li H
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):366-8. PubMed ID: 8732094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
    Yamada K; Ohkawa K; Joh K
    Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
    Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
    Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
    Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
    Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
    Aguirre P; Thor AD; Scully RE
    Am J Clin Pathol; 1989 Aug; 92(2):140-9. PubMed ID: 2474244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
    Macdonald F; Bird R; Stokes H; Russell B; Crocker J
    J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
    Chauhan SC; Singh AP; Ruiz F; Johansson SL; Jain M; Smith LM; Moniaux N; Batra SK
    Mod Pathol; 2006 Oct; 19(10):1386-94. PubMed ID: 16880776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benign and malignant Brenner tumor of the ovary: a clinicopathological and immunohistochemical study].
    Peng ZN
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):333-5. PubMed ID: 1284387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
    Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
    Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial markers to detect occult microinvasion in serous ovarian tumors.
    Hanselaar AG; Vooijs GP; Mayall B; Ras-Zeijlmans GJ; Chadha-Ajwani S
    Int J Gynecol Pathol; 1993 Jan; 12(1):20-7. PubMed ID: 7678103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of epithelial ovarian-cancer-associated antigens involved in immune complexes by monoclonal antibodies.
    Kawata M; Sekiya S
    Tumour Biol; 1998; 19(1):1-11. PubMed ID: 9422077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
    Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
    Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogenesis of Brenner tumors, II: histochemistry and CEA.
    Shevchuk MM; Fenoglio CM; Richart RM
    Cancer; 1980 Dec; 46(12):2617-22. PubMed ID: 7004621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localisation of carcinoembryonic antigen (CEA) in malignant epithelial ovarian tumours using monoclonal antibodies.
    Gogate N; Deshmukh S
    Indian J Pathol Microbiol; 1995 Apr; 38(2):199-201. PubMed ID: 8919110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic mucinous cystadenocarcinoma with pseudosarcomatous mural nodules. A report of a case with immunohistochemical study.
    García Rego JA; Valbuena Ruvira L; Alvarez García A; Santiago Freijanes MP; Suárez Peñaranda JM; Rois Soto JM
    Cancer; 1991 Jan; 67(2):494-8. PubMed ID: 1702351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.